Opioid-Related Disorders

The grounding supports opioid abuse or misuse as the direct cause of opioid-related disorders. The literature also notes that polysubstance use commonly overlaps with opioid use and can contribute to morbidity and mortality. Genetic susceptibility is described as influencing individual vulnerability to opioid addiction.

The disorder is described in the literature as involving addiction biology with relapse and remission, but the supplied grounding does not provide a detailed biological mechanism. Review material indicates that different opioids act on different opioid receptors and that genetic factors may shape vulnerability. Polysubstance use may also interact with opioid effects through additive or synergistic reward and other compensatory use patterns.

Risk is increased by opioid misuse, nonmedical opioid use, and polysubstance use. The literature also points to genetic susceptibility as a contributor to vulnerability. Overprescribing or prescribing opioids without adequate safeguards is discussed as part of the broader context of the opioid crisis.

Treatment is described at the level of medication-assisted or pharmacologic therapy, including methadone, buprenorphine, and naloxone. The CDC guideline grounding also emphasizes opioid prescribing decisions, dose selection, follow-up, and assessment of risk and harms in pain care. Harm-reduction strategies and improved access to treatment are also discussed in the literature.